Noninvasive Brain Stimulation for Lazy Eye
(NIBSAAM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether non-invasive brain stimulation can improve vision in adults with amblyopia, also known as lazy eye. Researchers aim to determine if this method has lasting effects on the brain's processing of visual information. Participants will receive either real stimulation (High-Frequency Transcranial Random Noise Stimulation) or a placebo-like sham treatment for comparison. Adults with a formal diagnosis of amblyopia are suitable candidates for this study. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new treatment options for amblyopia.
Will I have to stop taking my current medications?
If you are taking medications that affect normal neurological function, like antipsychotics, antiepileptics, or opioids, you may need to stop taking them to participate in this trial.
What prior data suggests that non-invasive brain stimulation is safe for treating amblyopia?
Research has shown that high-frequency transcranial random noise stimulation (hf-tRNS) is generally safe for people. A study on its use in adults with amblyopia, or "lazy eye," found improvements in vision without serious side effects. Participants attended daily sessions, and no major negative effects were reported. This suggests that hf-tRNS is a safe option for those considering joining a trial for amblyopia.12345
Why are researchers excited about this trial?
Researchers are excited about using High Frequency Transcranial Random Noise Stimulation (hf-tRNS) for treating lazy eye, or amblyopia, because it's a non-invasive and potentially faster alternative to traditional treatments like eye patches or corrective lenses. Unlike these standard methods, which can take weeks or even months to show significant improvement, hf-tRNS involves short, daily sessions over just five days. This technique works by gently stimulating the brain with random electrical noise, which may enhance neural plasticity and improve visual processing. If successful, hf-tRNS could offer a quicker, less cumbersome option for patients compared to the conventional approaches.
What evidence suggests that non-invasive brain stimulation is effective for treating amblyopia?
Research has shown that high-frequency transcranial random noise stimulation (hf-tRNS), a treatment that participants in this trial may receive, can significantly improve vision in adults with amblyopia, also known as lazy eye. Studies have found that this treatment clarifies vision and helps individuals distinguish objects more distinctly from their background. One study reported improved vision after just five days of treatment. Although amblyopia has long been considered untreatable in adults, these findings suggest that hf-tRNS could be a promising new method to enhance vision. Participants in this trial may also receive sham stimulation as a comparator.12456
Are You a Good Fit for This Trial?
This trial is for adults with amblyopia, commonly known as lazy eye. Participants should be interested in a non-surgical treatment option and available for five consecutive days of stimulation sessions. Specific eligibility details are not provided but typically include age range, severity of amblyopia, and general health requirements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either high-frequency transcranial random noise stimulation (hf-tRNS) or sham stimulation for 5 consecutive days
Follow-up
Participants are monitored for changes in visual functions and neural plasticity post-treatment
What Are the Treatments Tested in This Trial?
Interventions
- High Frequency Transcranial Random Noise Stimulation
- Sham Transcranial Random Noise Stimulation
Trial Overview
The study tests if brain stimulation can improve vision in adults with lazy eye. It compares high-frequency transcranial random noise stimulation (hf-tRNS) against sham (fake) treatment over five days to see if there's any improvement in visual functions like acuity and perception.
How Is the Trial Designed?
2
Treatment groups
Active Control
Placebo Group
40-minute sessions of hf-tRNS stimulation for 5 consecutive days.
40-minute sessions of sham stimulation for 5 consecutive days.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Midwestern University
Lead Sponsor
Published Research Related to This Trial
Citations
Differential effects of high-frequency transcranial random ...
There is evidence that extensive perceptual training can improve visual acuity (VA) and contrast sensitivity (CS) in adults with amblyopia.
Improving visual functions in adult amblyopia with ...
... hf-tRNS, were able to substantially improve VA and CSF in adults with amblyopia. Introduction. Amblyopia, sometimes referred to as “lazy eye,” is a ...
Differential effects of high-frequency transcranial random ...
Amblyopia or lazy eye is a dysfunction of the visual system that appears during childhood and traditionally has been considered untreatable ...
Repetitive visual cortex transcranial random noise ...
We tested the hypothesis that five daily sessions of visual cortex transcranial random noise stimulation would improve contrast sensitivity, crowded and ...
The impact of transcranial random noise stimulation (tRNS) ...
(2023) demonstrated that creativity and mind-wandering engage the DMN with different temporal dynamics. This study provides causal evidence ...
Daily high-frequency transcranial random noise stimulation (hf ...
The primary objective of this study is to examine the safety, feasibility, and effectiveness of hf-tRNS and 40 Hz tACS interventions targeting left IPL in ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.